Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties - Wikidata - wikimedia - TriplyDB

Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties

Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties

http://www.wikidata.org/entity/Q41945985

about

Interleukin-15 biology and its therapeutic implications in cancer The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use Immune Cells in Cancer Therapy and Drug Delivery Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy Dendritic cell-based immunity and vaccination against hepatitis C virus infection STAT3 signaling contributes to the high effector activities of interleukin-15-derived dendritic cells HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells Three-day dendritic cells for vaccine development: antigen uptake, processing and presentation.Quality controls in cellular immunotherapies: rapid assessment of clinical grade dendritic cells by gene expression profiling.Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cells Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner.Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory function.IL-15 Superagonist Expands mCD8+ T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection Enhancement of dendritic cells as vaccines for cancer Dendritic cell-based immunotherapy for myeloid leukemias.Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia.Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia.Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation.NK cells: key to success of DC-based cancer vaccines?Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells.Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy.Wilms' tumor gene 1 immunotherapy in pelvic gynecological malignancies.Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies-A review.Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists.Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells.Complex evaluation of human monocyte-derived dendritic cells for cancer immunotherapy.Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide.Comparative study of dendritic cells matured by using IL-1β, IL-6, TNF-α and prostaglandins E2 for different time span.Monocytes differentiated with GM-CSF and IL-15 initiate Th17 and Th1 responses that are contact-dependent and mediated by IL-15.Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer Immunotherapy.Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion.Remodeling of the epitope repertoire of a candidate idiotype vaccine by targeting to lysosomal degradation in dendritic cells

P2860

Q24595605-973A9EE1-D27F-482C-BBA2-E065ACE61AD7 Q24599103-7EE31E93-EAE3-400A-8D84-D2D04F7AEFCE Q26747061-277FBE8C-F3EE-4D5A-A771-C0B754B378A8 Q26765345-843F978E-BDA3-412C-9DF0-B55455F2B2F4 Q26781175-21012996-1D6A-4BA2-A143-410DAB428CBA Q26828003-6FA8E673-62F8-4B2E-8702-9B1AA940F4F9 Q28255371-8BC60833-6B46-4873-A14D-6A52B010646E Q34011491-3DD83C89-F50C-42B2-8876-95EA962518F6 Q34202646-ABA1DCB8-95E6-4832-B36B-D6D0BB01965E Q34311362-DD2520B5-C996-4F65-919A-AB6573161DBD Q34419349-E044044E-9A87-482A-8EFF-9EC1425413AB Q34532389-41D9F469-5440-4422-807B-6EC22EBB85A9 Q35624376-135E82CF-7DAC-47A4-887C-B0A3CE7EED84 Q35876990-8764240F-691B-4985-8B4D-0D7AA6567DBC Q35918321-A6337A0A-D94A-4DF8-A707-ACD75F7495D2 Q36209210-D779032D-C9CC-419F-A02A-6D33FC917DE0 Q37420778-9EF49B39-6F2C-4A87-8AA2-A1AC0D426E73 Q37868974-CED09EDE-A2DF-4829-8603-A5874EDB887C Q38015123-B180EEA0-719A-47EE-94DE-BF130A4428AB Q38031222-5B5273EA-9219-4CE9-B7C7-E976CF2EF5B3 Q38031280-99541924-4221-46FA-BC33-84030DB32CFE Q38036202-0FA064F9-75C6-4686-BEA5-878D07DA4444 Q38097034-86374B45-91EA-4461-8DB2-45A30EDDE3C6 Q38115438-71CDCC0A-E9A6-4997-9EC6-59FDDB24D3EA Q38208388-7ECA5203-4988-445A-A6AB-5570FAE45C31 Q38544057-4A702059-257B-49C7-9D5C-827C616E9EAF Q38672403-138248E7-F8A5-4325-8FB6-EB4F6EB6577D Q38836832-1570FA0D-0A3C-480A-A7C9-B3CC90AA390D Q39014899-CE29F263-06FA-4798-8E5A-07E832E2A946 Q39299639-41E6046D-7E43-456E-BAE1-A749001F1B38 Q39522977-73C16849-35AF-434C-8DE5-36F3FFB1512D Q40092538-D3753A94-9C0C-425D-B083-E0C2CA86F2CF Q40543232-8556D083-D9AF-4ECA-A2D1-DB14392BEFAD Q40733554-C9F80122-91FF-4362-A5D4-D64484ACBB26 Q52716912-E14B7CCC-1425-492B-96C4-73A90D5DAC32 Q57056029-DE7569C0-4D72-4872-9571-AB784A722DC3

P2860

Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties

http://www.wikidata.org/entity/Q41945985

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Short-term cultured, interleuk ...... t immunostimulatory properties

@en

type

label

Short-term cultured, interleuk ...... t immunostimulatory properties

@en

prefLabel

Short-term cultured, interleuk ...... t immunostimulatory properties

@en

P1433

Q41945985-E1EE2ACF-F7EA-4EBF-8F0A-089E74DCB5EE

P1476

Q41945985-C15A02B7-DC8E-4AA1-9631-0313FF50A1E5

P2093

Q41945985-161E6365-EFFB-4C95-B9BF-DD447BDF24D0

Q41945985-18B260C1-8388-4B73-9D19-6BC6E5BED5D3

Q41945985-3B0E4E37-BA65-4C65-87B1-DF43D7C6C98F

Q41945985-52869A3B-07B7-4548-8E68-FD9B1F2FE367

Q41945985-5DD3A994-9FF4-4CAE-BC94-ABB5EBF4179C

Q41945985-75BAFBD8-5123-487F-855C-1143B17419EB

P2860

Q41945985-0488EE5D-4522-4843-96C2-1F08AE8304CC

Q41945985-0890DD3B-8C9A-4D96-83F3-AB45847D1183

Q41945985-09206611-AF18-4D71-A816-BFD0E04AD3E8

Q41945985-0A429F7E-94E0-4F8A-968F-8B19BAB44089

Q41945985-0D932BC1-9E38-430D-A412-B9C976DFD5D3

Q41945985-1A6168F6-969A-4F6E-BC1B-19465B4A4CDF

Q41945985-1BEA835F-8162-44E5-8808-A62D9EF9AC55

Q41945985-1EFE5D1D-9BEB-4DEB-8F22-7838CB2636C5

Q41945985-2D14B8C8-A7D6-4644-983B-F6416CCD9EC5

Q41945985-2E7103E8-241E-44CD-95E2-2A3E9D898DE3

P2888

Q41945985-5FF5E6B3-6161-4D8D-AD71-EB59F1F7AF43

P304

Q41945985-546A79E0-866F-4E84-8E36-A4935AD6C05B

P31

Q41945985-03B77A11-E183-45E3-9944-B17A4FE0024D

P356

Q41945985-BC2D6215-5393-4254-B458-BACC47D1C326

P478

Q41945985-578E99EC-4FB1-4D43-AF6F-206FCF204F1C

P577

Q41945985-AC89702B-AFF1-4363-9514-B9527FCE233A

P5875

Q41945985-9C5C0FA4-D21E-401D-9FFB-7E9525430503

P6179

Q41945985-C2F204BD-A631-4F90-8E10-33C606B19CFC

P698

Q41945985-0668D1A1-7A6B-4BDC-813D-614CBB5135AE

P932

Q41945985-C5FA40C7-39F0-4B21-B6C1-966B7E8F60D0

P356

1479-5876-7-109

P1433

Journal of Translational Medicine

P1476

Short-term cultured, interleuk ...... t immunostimulatory properties

@en

P2093

Evelien L J M Smits

http://www.w3.org/2001/XMLSchema#string

Herman Goossens

http://www.w3.org/2001/XMLSchema#string

Nathalie Cools

http://www.w3.org/2001/XMLSchema#string

Sébastien Anguille

http://www.w3.org/2001/XMLSchema#string

Vigor F I Van Tendeloo

http://www.w3.org/2001/XMLSchema#string

Zwi N Berneman

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

Taking dendritic cells into medicine

A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines.

Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells.

Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes

Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs

Cancer immunotherapy using RNA-loaded dendritic cells.

Dendritic cell immunotherapy: mapping the way.

Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.

Messenger RNA electroporation: an efficient tool in immunotherapy and stem cell research.

P2888

1479-5876-7-109

P304

109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-7-109

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40729167

http://www.w3.org/2001/XMLSchema#string

P6179

1029736118

http://www.w3.org/2001/XMLSchema#string

P698

20021667

http://www.w3.org/2001/XMLSchema#string

P932

2807857

http://www.w3.org/2001/XMLSchema#string